ALDX - Holzer & Holzer LLC Reminds Investors of September 29 2023 Lead Plaintiff Deadline for Class Action Lawsuit Filed on Behalf of Aldeyra Therapeutics Inc. (ALDX) Investors – Nationally Ranked Investors' Rights Firm Encourages Investors With Significant L

ATLANTA, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC reminds investors that a class action lawsuit has been filed against Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ:ALDX). The lawsuit alleges Aldeyra made materially false and/or misleading statements and/or failed to disclose material adverse facts about the Company's business, operations, and compliance policies, including: (i) the ADX-2191 new drug application ("NDA") did not include adequate and well-controlled investigations and thus failed to show substantial evidence of ADX-2191's effectiveness; (ii) as a result, the FDA was unlikely to approve the ADX-2191 NDA in ...

ALDX) Investors – Nationally Ranked Investors' Rights Firm Encourages Investors With Significant Losses to Contact the Firm>Full story available on Benzinga.com